FDA Accepts Lexicon's New Drug Application For Review In Heart Failure Setting
Coherus's Refiling For Head and Neck Cancer Candidate Accepted By FDA For Review
U.S. FDA Accepts Emergent's Anthrax Vaccine Candidate Filing For Review
Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates